Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson's disease

Journal of Ethnopharmacology

Volumn 146, Issue 1, 2013, Pages 363-371

  Zhang, Yi ^a   Sun, Hong Mei ^a   He, Xin ^a   Wang, Yuan Yuan ^a   Gao, Yu Shan ^a   Wu, Hai Xia ^a   Xu, Hong ^a   Gong, Xiao Gang ^a   Guo, Zhen Yu ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Da Bu Yin Wan; Mitochondrial DNA damage; Mitochondrial subunit NADH dehydrogenase 1; Parkinson's disease; Qian Zheng San

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANEMARRHENA ASPHODELOIDES EXTRACT; ANTIPARKINSON AGENT; BOMBYX BATRYTICATUS EXTRACT; CHINESE DRUG; DA BU YIN WAN; MESSENGER RNA; MITOCHONDRIAL DNA; PAEONIA LACTIFLORA EXTRACT; PHELLODENDRON CHINENSE EXTRACT; PLANT EXTRACT; QIAN ZHENG SAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SCHISANDRA CHINENSIS EXTRACT; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANEMARRHENA ASPHODELOIDES; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOMBYX BATRYTICATUS; CONTROLLED STUDY; CORPUS STRIATUM; DNA DAMAGE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MEDICINAL PLANT; MOUSE; NEUROPROTECTION; NONHUMAN; PAEONIA LACTIFLORA; PARKINSON DISEASE; PHELLODENDRON CHINENSE; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHISANDRA CHINENSIS; SUBSTANTIA NIGRA; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PARKINSON DISEASE; PROTEINS; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 84874110721     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.01.005     Document Type: Article

References (54)

1. L. Amazzal, A. Lapotre, F. Quignon, and D. Bagrel Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells Neuroscience Letters 418 2007 159 164
2. S. Ayala-Torres, Y. Chen, T. Svoboda, J. Rosenblatt, and B. Van Houten Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction Methods 22 2000 135 147
3. L.M. Bekris, I.F. Mata, and C.P. Zabetian The genetics of Parkinson disease Journal of Geriatric Psychiatry and Neurology 23 2010 228 242
4. A. Bender, K.J. Krishnan, C.M. Morris, G.A. Taylor, A.K. Reeve, R.H. Perry, E. Jaros, J.S. Hersheson, J. Betts, T. Klopstock, R.W. Taylor, and D.M. Turnbull High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease Nature Genetics 38 2006 515 517
5. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience 3 2000 1301 1306
6. H. Braak, E. Ghebremedhin, U. Rub, H. Bratzke, and T.K. Del Stages in the development of Parkinson's disease-related pathology Cell and Tissue Research 318 2004 121 134
7. L. Cai, and Z. Chen Assaying the berberine hydrochloride in Da-Bu-Yin Wan by high-performance liquid chromatography Chinese Journal of Ethnomedicine and Ethnopharmacy 19 2010 39 (in Chinese)
8. J. Carroll, I.M. Fearnley, R.J. Shannon, J. Hirst, and J.E. Walker Analysis of the subunit composition of complex I from bovine heart mitochondria Molecular and Cellular Proteomics 2 2003 117 126
9. M. Carta, T. Carlsson, A. Munoz, D. Kirik, and A. Bjorklund Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias Progress in Brain Research 172 2008 465 478
10. C.W. Christine, and M.J. Aminoff Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance American Journal of Medicine 117 2004 412 419
11. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
12. A. Doo, S. Kim, J. Park, K.H. Cho, J. Hong, K. Eun-Kyung, S.K. Moon, W.S. Jung, H. Lee, J.H. Jung, and H. Park Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo Journal of Ethnopharmacology 131 2010 433 442
13. D.J. Doudet, G.L. Chan, J.E. Holden, E.G. McGeer, T.A. Aigner, R.J. Wyatt, and T.J. Ruth 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys Synapse 29 1998 225 232
14. G. Eisenhofer, I.J. Kopin, and D.S. Goldstein Catecholamine metabolism: a contemporary view with implications for physiology and medicine Pharmacological Reviews 56 2004 331 349
15. J.M. Fritschy Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry European Journal of Neuroscience 28 2008 2365 2370
16. X. He, Y.S. Gao, H.M. Sun, H.X. Wu, H. Xu, and Z.Y. Wang Effect of Dabuyin Pill and Qianzheng Powder on activity of mitochondrial enzyme complexes in mice with Parkinson's disease Jiangsu Journal of Traditional Chinese Medicine 42 2010 72 73 (in Chinese)
17. X. He, H.M. Sun, H.X. Wu, H. Xu, Y.Y. Wang, Y.S. Gao, Z.Y. Wang, G.L. Ge, and L.M. Bai Neuroprotective effect of Dabuyin Pill, Qianzheng Powder and combined formula on Parkinson's disease mice brain Liaoning Journal of Traditional Chinese Medicine 37 2010 2098 2101 (in Chinese)
18. R.E. Heikkila, A. Hess, and R.C. Duvoisin Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice Science 224 1984 1451 1453
19. C. Henchcliffe, and M.F. Beal Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature clinical practice Neurology 4 2008 600 609
20. J. Hirst Towards the molecular mechanism of respiratory complex I Biochemical Journal 425 2010 327 339
21. S.E. Hunter, D. Jung, R.T. Di Giulio, and J.N. Meyer The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number Methods 51 2010 444 451
22. G. Ibarretxe, M.V. Sanchez-Gomez, M.R. Campos-Esparza, E. Alberdi, and C. Matute Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols Glia 53 2006 201 211
23. A.E. Kingsbury, M. Cooper, A.H. Schapira, and O.J. Foster Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: an in situ hybridization study Annals of Neurology 50 2001 142 149
24. A.J. Lees, J. Hardy, and T. Revesz Parkinson's disease Lancet 373 2009 2055 2066
25. N. Li Clinical observation on Parkinson's disease patients with treatement of traditional Chinese medicine Chinese Journal of Geriatric Care 7 2009 100 101 (in Chinese)
26. H.L. Liao, W.X. Wang, F.S. Zhao, G.M. Ye, and Q.Y. Wu Progress of studies on chemical constituents of Anemarrhena asphodeloides Journal of Pharmaceutical Practice 23 2005 12 14 (in Chinese)
27. J. Liu, H. Wang, L. Zhang, Y. Xu, W. Deng, H. Zhu, and C. Qin S100B transgenic mice develop features of Parkinson's disease Archives of Medical Research 42 2011 1 7
28. -ΔΔCT method Methods 25 2001 402 408
29. G. Lunardi, S. Galati, D. Tropepi, V. Moschella, L. Brusa, M. Pierantozzi, A. Stefani, S. Rossi, F. Fornai, E. Fedele, P. Stanzione, A.H. Hainsworth, and A. Pisani Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease Parkinsonism and Related Disorders 15 2009 383 389
30. W.J. Nicklas, I. Vyas, and R.E. Heikkila Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sciences 36 1985 2503 2508
31. S.A. Nunez, C.H. Velez, J. Aguero-Aguero, J. Gonzalez-Gonzalez, F. Naddeo, F. De Simone, and L. Rastrelli Isolation and quantitative analysis of phenolic antioxidants, free sugars, and polyols from mango (Mangifera indica L.) stem bark aqueous decoction used in Cuba as a nutritional supplement Journal of Agricultural and Food Chemistry 50 2002 762 766
32. N. Ogawa, Y. Hirose, S. Ohara, T. Ono, and Y. Watanabe A simple quantitative bradykinesia test in MPTP-treated mice Research Communications in Chemical Pathology and Pharmacology 50 1985 435 -341
33. A.G. Pardo, N. Maurmann, G.K. Reolon, C.B. de Farias, G. Schwartsmann, R. Delgado, and R. Roesler Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats European Journal of Pharmacology 635 2010 124 128
34. Rascol, O., Payoux, P., Ory, F., Ferreira, J.J., Brefel-Courbon, C., Montastruc, J.L., 2003. Limitations of current Parkinson's disease therapy. Annals of Neurology 53 Suppl 3, S3-12; discussion S12-S15.
35. M. Ruberg, B. Brugg, A. Prigent, E. Hirsch, A. Brice, and Y. Agid Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? Journal of Neurochemistry 68 1997 2098 2110
36. A.H. Schapira, J.M. Cooper, D. Dexter, J.B. Clark, P. Jenner, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Journal of Neurochemistry 54 1990 823 827
37. R.H. Swerdlow, J.K. Parks, S.W. Miller, J.B. Tuttle, P.A. Trimmer, J.P. Sheehan, J.J. Bennett, R.E. Davis, and W.J. Parker Origin and functional consequences of the complex I defect in Parkinson's disease Annals of Neurology 40 1996 663 671
38. L. Tretter, I. Sipos, and V. Adam-Vizi Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease Neurochemical Research 29 2004 569 577
39. J. Vidal, J. Bie, R.A. Granneman, A.E. Wallinga, J.M. Koolhaas, and B. Buwalda Social stress during adolescence in Wistar rats induces social anxiety in adulthood without affecting brain monoaminergic content and activity Physiology and Behavior 92 2007 824 830
40. R. Vogel, L. Nijtmans, C. Ugalde, L. van den Heuvel, and J. Smeitink Complex I assembly: a puzzling problem Current Opinion in Neurology 17 2004 179 186
41. D.C. Wallace Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256 1992 628 632
42. D.C. Wallace Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine Annual Review of Biochemistry 76 2007 781 821
43. Y. Wang, and Y. Zhao Immune-pharmacology study on the immunoregulatory effects of Dabuyin Wan in autoimmune mice induced by Campylobacter jejuni Zhong Yao Cai 30 2007 567 570 (in Chinese)
44. Z.Z. Wang, Y. Zhang, Y.Q. Liu, N. Zhao, Y.Z. Zhang, L. Yuan, L. An, J. Li, X.Y. Wang, J.J. Qin, S.P. Wilson, J.M. O'Donnell, H.T. Zhang, and Y.F. Li RNA interference-mediated phosphodiesterase-4D splice variants knockdown in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects British Journal of Pharmacology 168 2013 1001 1014
45. Z.Z. Wang, Y. Zhang, Y.H. Yuan, and N.H. Chen Developmental expression of chemokine-like factor 1, a novel member of chemokines family, in postnatal rat cerebral cortex Neuroscience Letters 519 2012 51 55
46. H. Weiss, T. Friedrich, G. Hofhaus, and D. Preis The respiratory-chain NADH dehydrogenase (complex I) of mitochondria European Journal of Biochemistry 197 1991 563 576
47. C. Zai, and X. Gu Review on Parkinson's disease treatment by TCM Guangming Journal of Chinese Medicine 24 2009 169 171 (in Chinese)
48. J. Zhang, T.J. Montine, M.A. Smith, S.L. Siedlak, G. Gu, D. Robertson, and G. Perry The mitochondrial common deletion in Parkinson's disease and related movement disorders Parkinsonism and Related Disorders 8 2002 165 170
49. Y. Zhang, and P.P. Li Shu-Gan-Liang-Xue Decoction, a Chinese herbal formula, down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7 cells Journal of Ethnopharmacology 127 2010 620 624
50. Y. Zhang, and P.P. Li Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-luciferase reporter based bioluminescent measurements in vitro Journal of Ethnopharmacology 126 2009 345 349
51. Y. Zhang, R.Q. Qian, and P.P. Li Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells Cancer Letters 284 2009 47 54
52. Y. Zhang, Z.Z. Wang, and H.M. Sun Lack of association between p.Ser167Asn variant of Parkin and Parkinson's disease: A meta-analysis of 15 studies involving 2280 cases and 2459 controls American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159B 2012 38 47
53. Y. Zhang, Z.Z. Wang, and H.M. Sun Meta-analysis of the influence of Parkin p.Asp394Asn variant on the susceptibility of Parkinson's disease Neuroscience Letters 524 2012 60 64
54. Z.Q. Zhang Clinical application of Qian-Zheng-San Sichuan Journal of Tradition Chinese Medicine 3 1991 11 12 (in Chinese)